Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)

计划入组 20 人 · 首次发布于 2015 年 5 月 21 日

Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine

计划入组 112 人 · 首次发布于 2011 年 9 月 19 日

Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine

计划入组 58 人 · 首次发布于 2012 年 1 月 10 日

TetraVax-DV-TV005

TetraVax-DV-TV003 (Butantan Institute)

T0003

Dengue Vaccine Landscape Evolves: New Candidates Show Promise in Clinical Trials

Phase 3 Trial of India's First Indigenous Dengue Vaccine, 'DengiAll,' Commences

India Launches First Indigenous Dengue Vaccine Phase 3 Trial with Over 10,000 Participants